$Treatment of refractory Hodgkin's disease with modified Stanford V program$

Treatment of refractory Hodgkin's disease with modified Stanford V program

This study analyzes the results using an Stanford V modified program in the treatment of refractory Hodgkin's disease (RHD). We used cyclophosphamide instead of mechloretamine, and epirubicin instead of doxorubicin to avoid the risk of acute and late side effects associated with this drugs. Sev...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical oncology (Northwood, London, England) London, England), 2001-01, Vol.18 (4), p.261-268
Hauptverfasser:	Avilés, A, Neri, N, García, E L, Talavera, A, Díaz-Maqueo, J C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bleomycin - administration & dosage Cyclophosphamide - administration & dosage Epirubicin - administration & dosage Etoposide - administration & dosage Female Hodgkin Disease - drug therapy Humans Male Middle Aged Neoplasm Recurrence, Local - drug therapy Oncology Prednisone - administration & dosage Remission Induction Salvage Therapy Survival Analysis Vinblastine - administration & dosage Vincristine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!